Inventor

LEE KANG CHOON

KR10 patents

⚠️ This page may combine multiple inventors who share the name “LEE KANG CHOON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LEE KANG CHOON

3 patents

US8420598B2Apr 16, 2013

Mono modified exendin with polyethylene glycol or its derivatives and uses thereof

LEE KANG CHOON9 citations79

US9321825B2Apr 26, 2016

N-terminal modified PEG-TRAIL

LEE KANG CHOON2 citations57

US8466103B2Jun 18, 2013

Exendin polypeptide linked to biotin, method for the preparation thereof and pharmaceutical composition comprising the same

LEE KANG CHOON0 citations41

THERALY PHARMACEUTICALS INC

2 patents

US9901620B2Feb 27, 2018

Trail receptor agonists for treatment of fibrotic disease

THERALY PHARMACEUTICALS INC3 citations68

US10046059B2Aug 14, 2018

Methods of administering an N-terminal modified PEG-TRAIL

THERALY PHARMACEUTICALS INC1 citations48

D&D PHARMATECH INC

2 patents

US12338270B2Jun 24, 2025

Pharmaceutical composition comprising polypeptide

D&D PHARMATECH INC0 citations52

US11299528B2Apr 12, 2022

Long acting TRAIL receptor agonists for treatment of autoimmune diseases

D&D PHARMATECH INC0 citations48

(unassigned)

1 patent

US6506730B1Jan 14, 2003

Nasal transmucosal delivery of peptide conjugated with biocompatible polymers

94 citations94

THERALY FIBROSIS INC

1 patent

US11767353B2Sep 26, 2023

Trail compositions with reduced immunogenicity

THERALY FIBROSIS INC1 citations49

PEGSPHERE CO LTD

1 patent

US7662915B2Feb 16, 2010

Peptides having protected amines of untargeted sites, methods for production thereof and of specifically conjugated PEG peptides using the same

PEGSPHERE CO LTD0 citations39